Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Abstract As a promising therapeutic strategy, oncolytic virotherapy has shown potent anticancer efficacy in numerous pre-clinical and clinical trials. Oncolytic viruses have the capacity for conditional-replication within carcinoma cells leading to cell death via multiple mechanisms, including direc...
Main Authors: | Bin Zhang, Ping Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12943-020-01275-6 |
Similar Items
-
Oncolytic Virotherapy of Canine and Feline Cancer
by: Ivaylo Gentschev, et al.
Published: (2014-05-01) -
Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
by: Olga V. Matveeva, et al.
Published: (2020-12-01) -
Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
by: Junior A. Enow, et al.
Published: (2023-11-01) -
Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01) -
Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection
by: Tarryn Bourhill, et al.
Published: (2018-08-01)